Opioid Overdose Treatment Market is Projected to Reach US$ 3.1 Billion by 2034 | Fact.MR Report
September 09, 2024 06:00 ET
|
FACT.MR
Rockville, MD, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The global opioid overdose treatment market is expected to reach a value of US$ 1.54 billion in 2024, as revealed in a new industry analysis...
Harm Reduction Therapeutics Marks International Overdose Awareness Day With Free Donations of RiVive™ Life-Saving Over-The-Counter Naloxone Nasal Spray
September 03, 2024 07:00 ET
|
Harm Reduction Therapeutics
Donations continue to Remedy Alliance/For The People where it is being distributed to under-resourced harm reduction organizations across the U.S.Additional donations of RiVive™ have been made to...
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
August 30, 2024 08:16 ET
|
Emergent BioSolutions
For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN® Nasal SprayIn recognition of...
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
August 28, 2024 08:00 ET
|
Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people...
New Era Rehabilitation Center Highlights Comprehensive Outpatient Medication-Assisted Treatment Programs
August 20, 2024 10:55 ET
|
New Era Rehabilitation Center
New Haven, CT , Aug. 20, 2024 (GLOBE NEWSWIRE) -- New Era Rehabilitation Center, a leading provider of behavioral health and substance abuse treatment, offers comprehensive outpatient...
FLINT COOPER ATTORNEY ALEX PARKER APPOINTED TO LEADERSHIP DEVELOPMENT COMMITTEE IN SUBOXONE MULTIDISTRICT LITIGATION
August 14, 2024 14:57 ET
|
FLINT COOPER
EDWARDSVILLE, IL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Flint Cooper is proud to announce that Alex Parker has been appointed to the Leadership Development Committee (LDC) for the Suboxone...
Emergent BioSolutions Reports Second Quarter 2024 Financial Results
August 06, 2024 17:01 ET
|
Emergent BioSolutions
Second Quarter 2024 Total Revenues of $254.7 million, above the prior guidance rangeSecond Quarter 2024 Net Loss of $283.1 million and Adjusted EBITDA of $(10.1) millionUpdates FY 2024 guidance ...
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
August 06, 2024 08:00 ET
|
Emergent BioSolutions
Customer-focused approach and continued investments in NARCAN® Nasal Spray supply-readiness efforts help ensure opioid emergency preparedness GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE)...
Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
July 31, 2024 07:00 ET
|
Teva Pharmaceutical Industries Ltd
For an accessible version of this Press Release, please visit www.tevapharm.com Q2 2024 revenues of $4.2 billion reflecting an increase of 7% in U.S. dollars or 11% in local...
Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
July 24, 2024 07:30 ET
|
Emergent BioSolutions
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE...